Bicocca Open Archive

Logo unimib boa
BONFANTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.597
EU - Europa 7.027
AS - Asia 3.651
SA - Sud America 325
AF - Africa 50
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.433
IT - Italia 2.094
SG - Singapore 1.689
DE - Germania 1.337
IE - Irlanda 942
SE - Svezia 911
RU - Federazione Russa 848
HK - Hong Kong 770
CN - Cina 382
ID - Indonesia 368
BR - Brasile 272
GB - Regno Unito 227
VN - Vietnam 146
AT - Austria 123
CA - Canada 113
FI - Finlandia 102
IN - India 100
UA - Ucraina 93
NL - Olanda 89
FR - Francia 66
TR - Turchia 53
RO - Romania 49
MX - Messico 39
PH - Filippine 25
BE - Belgio 22
CO - Colombia 20
CZ - Repubblica Ceca 20
ES - Italia 20
JP - Giappone 19
IR - Iran 14
PK - Pakistan 12
DK - Danimarca 11
CH - Svizzera 10
AR - Argentina 9
CL - Cile 9
GR - Grecia 9
KR - Corea 9
ZA - Sudafrica 9
BG - Bulgaria 8
KE - Kenya 8
LT - Lituania 7
PE - Perù 7
TH - Thailandia 7
AL - Albania 6
AU - Australia 6
MY - Malesia 6
PL - Polonia 6
IL - Israele 5
JO - Giordania 5
MA - Marocco 5
NZ - Nuova Zelanda 5
SC - Seychelles 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
BD - Bangladesh 4
EG - Egitto 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
BY - Bielorussia 3
EC - Ecuador 3
EE - Estonia 3
GH - Ghana 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
MU - Mauritius 3
NO - Norvegia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CR - Costa Rica 2
ET - Etiopia 2
IQ - Iraq 2
LV - Lettonia 2
MM - Myanmar 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
A1 - Anonimo 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CM - Camerun 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
Totale 21.655
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.463
Singapore 1.312
Frankfurt am Main 1.145
Dublin 914
Fairfield 781
Hong Kong 767
Chandler 748
New York 589
Santa Clara 569
Milan 489
Ashburn 440
Wilmington 409
Woodbridge 403
Princeton 385
Jakarta 366
Houston 359
Seattle 301
Cambridge 223
Altamura 206
Lawrence 179
San Diego 114
Dong Ket 109
London 91
Nuremberg 91
Shanghai 90
Jacksonville 77
Vienna 77
Rome 74
Helsinki 67
Andover 61
Chicago 59
Guangzhou 57
Dearborn 54
Boardman 48
Falls Church 44
Galati 43
Toronto 42
Pune 41
Los Angeles 38
Fremont 36
Monza 36
Council Bluffs 34
Beijing 32
Nanjing 31
Florence 27
Norwalk 24
Lissone 23
Turin 21
Brussels 20
Lappeenranta 20
Ottawa 20
São Paulo 20
Washington 18
Brno 17
Cuauhtémoc 17
Naples 17
Palermo 17
Bogotá 16
Brescia 16
Lachine 15
Istanbul 14
Munich 14
Dallas 13
Hangzhou 13
Padova 13
Redmond 13
Shenzhen 13
Carate Brianza 12
Jinan 12
Busto Arsizio 11
Groningen 11
Hyderabad 11
Rio de Janeiro 11
Amsterdam 10
Bologna 10
Genoa 10
Kilburn 10
Kocaeli 10
Kolkata 10
Manila 10
Paris 10
Pisa 10
Romola 10
Acquafredda 9
Bari 9
Belo Horizonte 9
Huizen 9
Mexico City 9
Moscow 9
Catania 8
Cologno Monzese 8
Desio 8
Nairobi 8
Perugia 8
Peschiera Borromeo 8
Tianjin 8
Tokyo 8
Verona 8
Zurich 8
Atlanta 7
Totale 15.204
Salva come PNG Salva come JPEG
Nome #
Methotrexate inhibits SARS-CoV-2 virus replication "in vitro" 421
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 361
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 244
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 233
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 227
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 212
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting 207
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 207
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 204
A second update on mapping the human genetic architecture of COVID-19 203
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 199
Delirium in Patients with SARS‐CoV‐2 Infection: A Multicenter Study 194
An immune-based biomarker signature is associated with mortality in COVID-19 patients 193
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare 192
Mapping the human genetic architecture of COVID-19 189
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 181
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 180
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 180
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy 180
High rates of 30-day mortality in patients with cirrhosis and COVID-19 179
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 179
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 177
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 174
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 171
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 167
Infezione disseminata da Mycobacterium avium complex con batteriemia persistente in un paziente AIDS-presenter [Disseminated Mycobacterium avium complex infection with persistent bacteremia in an AIDS-presenter patient] 166
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 165
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study 164
Alternative pre-analytical strategies for SARS CoV 2 RNA detection 162
Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? 159
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006) 155
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 153
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 151
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 150
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 148
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 146
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 145
HIV and metabolic syndrome - A comparison with the general population 143
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 137
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 136
Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study 135
The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: A randomized multicentric study 135
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 133
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data 132
Anti-SARS-CoV-2 IgG antibodies induced by the BNT162b2 mRNA vaccine is age-dependent and influenced by a previous natural SARS-CoV-2 infection 132
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 131
Assessing the mortality risk in older patients hospitalized with a diagnosis of sepsis: the role of frailty and acute organ dysfunction 128
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 127
The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID study 126
Streptococcus agalactiae infective endocarditis complicated by multiple mycotic hepatic aneurysms and massive splenic infarction: A case report 122
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 121
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013 118
Frailty index predicts poor outcome in COVID-19 patients 118
Beware of biases in observational studies on anti-spike monoclonal antibodies 118
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 115
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 113
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 111
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible from the STOPSHIV Project Cohort 110
Being a Doctor Will Never Be the Same After the COVID-19 Pandemic 109
Weight gain: A possible side effect of all antiretrovirals 109
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 108
Pillars of long-term antiretroviral therapy success 107
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 104
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 103
Steroids in severe COVID-19 patients: A retrospective analysis on the first pandemics in Lombardy 103
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 102
Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients 102
A multidisciplinary approach to screen the post-COVID-19 conditions 101
Atrial Fibrillation Incidence in SARS-COV-2 Infected Patients: Predictors and Relationship with in-Hospital Mortality 100
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 100
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 100
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 99
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 99
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti? 97
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 97
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 96
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: A longitudinal study 95
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 94
Factors Associated With Weight Gain in People Treated With Dolutegravir 94
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 93
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 91
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 91
Osteonecrosis in human immunodeficiency virus (HIV)-infected patients: A multicentric case-control study 90
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 89
Factors associated with hospital admission for COVID-19 in HIV patients 89
Compassionate Use of Remdesivir in Children With Severe COVID-19 89
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 88
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 87
New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: A budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy) 84
Atrial fibrillation and clinical outcomes in a cohort of hospitalized patients with sars-cov-2 infection and chronic kidney disease 84
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 82
Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19 81
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 79
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir 78
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 78
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project 77
HEFFICON: HIV effectiveness Italian conference 76
Disuguaglianze sanitarie e malattie infettive:molto ancora da fare 76
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 76
Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19? 74
Totale 13.630
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.010
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020307 0 0 0 0 0 0 0 0 46 24 101 136
2020/20213.854 91 158 232 319 314 410 248 385 518 394 329 456
2021/20222.857 306 319 311 238 160 207 117 201 169 124 194 511
2022/20234.492 587 1.070 440 387 359 707 98 236 290 71 136 111
2023/20243.837 150 117 223 136 475 923 622 127 358 147 80 479
2024/20256.192 646 1.407 679 529 847 706 757 331 290 0 0 0
Totale 22.640